Art. -Nr.: HY-14374

GPP78

(Synonyms: CAY10618)

1 Cited Publications

Kundenbewertung

Based on 1 publication(s) in Google Scholar

GPP78 (CAY10618) is a potent Nampt inhibitor with an IC₅₀ of 3.0 nM for nicotinamide adenine dinucleotide (NAD) depletion. GPP78 is cytotoxic to neuroblastoma cell line SH-SY5Y cells with an IC₅₀ of 3.8 nM by inducing autophagy. GPP78 has anti-cancer and anti-inflammatory effects.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Reinheit: 99.9%
CAS. Nr.: 1202580-59-3
Formel: C₂₇H₂₉N₅O
Molecular Weight:439.55

Speicherung:

Solution, -20°C, 2 years

GPP78 Chemical Structure

CAS. Nr.: 1202580-59-3

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- Cellular Effect
- In Vitro
- In Vivo
Chemical Information
Publications (1)
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

IC₅₀ & Target

Nampt^[1];
Autophagy^[1]

Cellular Effect

Cell Line	Type	Value	Description	References
786-0	GI₅₀	7.33 μM Compound: 8	Growth inhibition of human 786-0 cells by sulforhodamine B assay Growth inhibition of human 786-0 cells by sulforhodamine B assay	[PMID: 19961183]
786-0	GI₅₀	7.33 x 10^-6 M Compound: 8	Growth inhibition of human 786-0 cells by sulforhodamine B assay Growth inhibition of human 786-0 cells by sulforhodamine B assay	[PMID: 19961183]
A498	GI₅₀	1.59 x 10^-5 M Compound: 8	Growth inhibition of human A498 cells by sulforhodamine B assay Growth inhibition of human A498 cells by sulforhodamine B assay	[PMID: 19961183]
A549	GI₅₀	2.1 μM Compound: 8	Growth inhibition of human A549 cells by sulforhodamine B assay Growth inhibition of human A549 cells by sulforhodamine B assay	[PMID: 19961183]
A549	GI₅₀	2.1 x 10^-6 M Compound: 8	Growth inhibition of human A549 cells by sulforhodamine B assay Growth inhibition of human A549 cells by sulforhodamine B assay	[PMID: 19961183]
ACHN	GI₅₀	1.87 x 10^-5 M Compound: 8	Growth inhibition of human ACHN cells by sulforhodamine B assay Growth inhibition of human ACHN cells by sulforhodamine B assay	[PMID: 19961183]
BT-549	GI₅₀	1.7 μM Compound: 8	Growth inhibition of human BT549 cells by sulforhodamine B assay Growth inhibition of human BT549 cells by sulforhodamine B assay	[PMID: 19961183]
BT-549	GI₅₀	1.7 x 10^-6 M Compound: 8	Growth inhibition of human BT549 cells by sulforhodamine B assay Growth inhibition of human BT549 cells by sulforhodamine B assay	[PMID: 19961183]
CAKI-1	GI₅₀	7.76 x 10^-7 M Compound: 8	Growth inhibition of human Caki1 cells by sulforhodamine B assay Growth inhibition of human Caki1 cells by sulforhodamine B assay	[PMID: 19961183]
CAKI-1	GI₅₀	7.76 x 10^-1 μM Compound: 8	Growth inhibition of human Caki1 cells by sulforhodamine B assay Growth inhibition of human Caki1 cells by sulforhodamine B assay	[PMID: 19961183]
CCRF-CEM	GI₅₀	3.28 μM Compound: 8	Growth inhibition of human CCRF-CEM cells by sulforhodamine B assay Growth inhibition of human CCRF-CEM cells by sulforhodamine B assay	[PMID: 19961183]
CCRF-CEM	GI₅₀	3.28 x 10^-6 M Compound: 8	Growth inhibition of human CCRF-CEM cells by sulforhodamine B assay Growth inhibition of human CCRF-CEM cells by sulforhodamine B assay	[PMID: 19961183]
COLO 205	GI₅₀	1.18 μM Compound: 8	Growth inhibition of human COLO205 cells by sulforhodamine B assay Growth inhibition of human COLO205 cells by sulforhodamine B assay	[PMID: 19961183]
COLO 205	GI₅₀	1.18 x 10^-6 M Compound: 8	Growth inhibition of human COLO205 cells by sulforhodamine B assay Growth inhibition of human COLO205 cells by sulforhodamine B assay	[PMID: 19961183]
DU-145	GI₅₀	7.02 x 10^-7 M Compound: 8	Growth inhibition of human DU145 cells by sulforhodamine B assay Growth inhibition of human DU145 cells by sulforhodamine B assay	[PMID: 19961183]
DU-145	GI₅₀	7.02 x 10^-1 μM Compound: 8	Growth inhibition of human DU145 cells by sulforhodamine B assay Growth inhibition of human DU145 cells by sulforhodamine B assay	[PMID: 19961183]
EKVX	GI₅₀	8.46 μM Compound: 8	Growth inhibition of human EKVX cells by sulforhodamine B assay Growth inhibition of human EKVX cells by sulforhodamine B assay	[PMID: 19961183]
EKVX	GI₅₀	8.46 x 10^-6 M Compound: 8	Growth inhibition of human EKVX cells by sulforhodamine B assay Growth inhibition of human EKVX cells by sulforhodamine B assay	[PMID: 19961183]
HCC 2998	GI₅₀	7 x 10^-7 M Compound: 8	Growth inhibition of human HCC2998 cells by sulforhodamine B assay Growth inhibition of human HCC2998 cells by sulforhodamine B assay	[PMID: 19961183]
HCC 2998	GI₅₀	7 x 10^-1 μM Compound: 8	Growth inhibition of human HCC2998 cells by sulforhodamine B assay Growth inhibition of human HCC2998 cells by sulforhodamine B assay	[PMID: 19961183]
HCT-116	GI₅₀	4.03 x 10^-8 M Compound: 8	Growth inhibition of human HCT116 cells by sulforhodamine B assay Growth inhibition of human HCT116 cells by sulforhodamine B assay	[PMID: 19961183]
HCT-116	GI₅₀	4.03 x 10^-2 μM Compound: 8	Growth inhibition of human HCT116 cells by sulforhodamine B assay Growth inhibition of human HCT116 cells by sulforhodamine B assay	[PMID: 19961183]
HCT-15	GI₅₀	2.57 x 10^-7 M Compound: 8	Growth inhibition of human HCT15 cells by sulforhodamine B assay Growth inhibition of human HCT15 cells by sulforhodamine B assay	[PMID: 19961183]
HCT-15	GI₅₀	2.57 x 10^-1 μM Compound: 8	Growth inhibition of human HCT15 cells by sulforhodamine B assay Growth inhibition of human HCT15 cells by sulforhodamine B assay	[PMID: 19961183]
HOP-62	GI₅₀	2.38 x 10^-5 M Compound: 8	Growth inhibition of human HOP62 cells by sulforhodamine B assay Growth inhibition of human HOP62 cells by sulforhodamine B assay	[PMID: 19961183]
HOP-92	GI₅₀	9.74 x 10^-5 M Compound: 8	Growth inhibition of human HOP92 cells by sulforhodamine B assay Growth inhibition of human HOP92 cells by sulforhodamine B assay	[PMID: 19961183]
Hs-578T	GI₅₀	2.04 x 10^-5 M Compound: 8	Growth inhibition of human Hs 578T cells by sulforhodamine B assay Growth inhibition of human Hs 578T cells by sulforhodamine B assay	[PMID: 19961183]
HT-29	GI₅₀	4.6 x 10^-7 M Compound: 8	Growth inhibition of human HT-29 cells by sulforhodamine B assay Growth inhibition of human HT-29 cells by sulforhodamine B assay	[PMID: 19961183]
HT-29	GI₅₀	4.6 x 10^-1 μM Compound: 8	Growth inhibition of human HT-29 cells by sulforhodamine B assay Growth inhibition of human HT-29 cells by sulforhodamine B assay	[PMID: 19961183]
IGROV-1	GI₅₀	2.72 x 10^-7 M Compound: 8	Growth inhibition of human IGROV1 cells by sulforhodamine B assay Growth inhibition of human IGROV1 cells by sulforhodamine B assay	[PMID: 19961183]
IGROV-1	GI₅₀	2.72 x 10^-1 μM Compound: 8	Growth inhibition of human IGROV1 cells by sulforhodamine B assay Growth inhibition of human IGROV1 cells by sulforhodamine B assay	[PMID: 19961183]
KM12	GI₅₀	1.03 μM Compound: 8	Growth inhibition of human KM12 cells by sulforhodamine B assay Growth inhibition of human KM12 cells by sulforhodamine B assay	[PMID: 19961183]
KM12	GI₅₀	1.03 x 10^-6 M Compound: 8	Growth inhibition of human KM12 cells by sulforhodamine B assay Growth inhibition of human KM12 cells by sulforhodamine B assay	[PMID: 19961183]
LOX IMVI	GI₅₀	1.01 x 10^-5 M Compound: 8	Growth inhibition of human LOXIMVI cells by sulforhodamine B assay Growth inhibition of human LOXIMVI cells by sulforhodamine B assay	[PMID: 19961183]
M14	GI₅₀	1.66 x 10^-7 M Compound: 8	Growth inhibition of human M14 cells by sulforhodamine B assay Growth inhibition of human M14 cells by sulforhodamine B assay	[PMID: 19961183]
M14	GI₅₀	1.66 x 10^-1 μM Compound: 8	Growth inhibition of human M14 cells by sulforhodamine B assay Growth inhibition of human M14 cells by sulforhodamine B assay	[PMID: 19961183]
Malme-3M	GI₅₀	1.22 x 10^-5 M Compound: 8	Growth inhibition of human MALME-3M cells by sulforhodamine B assay Growth inhibition of human MALME-3M cells by sulforhodamine B assay	[PMID: 19961183]
MCF7	GI₅₀	3.42 μM Compound: 8	Growth inhibition of human MCF7 cells by sulforhodamine B assay Growth inhibition of human MCF7 cells by sulforhodamine B assay	[PMID: 19961183]
MCF7	GI₅₀	3.42 x 10^-6 M Compound: 8	Growth inhibition of human MCF7 cells by sulforhodamine B assay Growth inhibition of human MCF7 cells by sulforhodamine B assay	[PMID: 19961183]
MDA-MB-231	GI₅₀	2.09 x 10^-5 M Compound: 8	Growth inhibition of human MDA-MB-231 cells by sulforhodamine B assay Growth inhibition of human MDA-MB-231 cells by sulforhodamine B assay	[PMID: 19961183]
MDA-MB-435	GI₅₀	3.99 x 10^-7 M Compound: 8	Growth inhibition of human MDA-MB-435 cells by sulforhodamine B assay Growth inhibition of human MDA-MB-435 cells by sulforhodamine B assay	[PMID: 19961183]
MDA-MB-435	GI₅₀	3.99 x 10^-1 μM Compound: 8	Growth inhibition of human MDA-MB-435 cells by sulforhodamine B assay Growth inhibition of human MDA-MB-435 cells by sulforhodamine B assay	[PMID: 19961183]
MDA-MB-468	GI₅₀	7.34 μM Compound: 8	Growth inhibition of human MDA-MB-468 cells by sulforhodamine B assay Growth inhibition of human MDA-MB-468 cells by sulforhodamine B assay	[PMID: 19961183]
MDA-MB-468	GI₅₀	7.34 x 10^-6 M Compound: 8	Growth inhibition of human MDA-MB-468 cells by sulforhodamine B assay Growth inhibition of human MDA-MB-468 cells by sulforhodamine B assay	[PMID: 19961183]
NCI/ADR-RES	GI₅₀	8.14 x 10^-8 M Compound: 8	Growth inhibition of human NCI/ADR-RES cells by sulforhodamine B assay Growth inhibition of human NCI/ADR-RES cells by sulforhodamine B assay	[PMID: 19961183]
NCI/ADR-RES	GI₅₀	8.14 x 10^-2 μM Compound: 8	Growth inhibition of human NCI/ADR-RES cells by sulforhodamine B assay Growth inhibition of human NCI/ADR-RES cells by sulforhodamine B assay	[PMID: 19961183]
NCI-H226	GI₅₀	1.55 x 10^-5 M Compound: 8	Growth inhibition of human NCI-H226 cells by sulforhodamine B assay Growth inhibition of human NCI-H226 cells by sulforhodamine B assay	[PMID: 19961183]
NCI-H23	GI₅₀	1.51 x 10^-5 M Compound: 8	Growth inhibition of human NCI-H23 cells by sulforhodamine B assay Growth inhibition of human NCI-H23 cells by sulforhodamine B assay	[PMID: 19961183]
NCI-H322M	GI₅₀	2.31 x 10^-5 M Compound: 8	Growth inhibition of human NCI-H322M cells by sulforhodamine B assay Growth inhibition of human NCI-H322M cells by sulforhodamine B assay	[PMID: 19961183]
NCI-H460	GI₅₀	7.24 x 10^-7 M Compound: 8	Growth inhibition of human NCI-H460 cells by sulforhodamine B assay Growth inhibition of human NCI-H460 cells by sulforhodamine B assay	[PMID: 19961183]
NCI-H460	GI₅₀	7.24 x 10^-1 μM Compound: 8	Growth inhibition of human NCI-H460 cells by sulforhodamine B assay Growth inhibition of human NCI-H460 cells by sulforhodamine B assay	[PMID: 19961183]
NCI-H522	GI₅₀	9.14 x 10^-8 M Compound: 8	Growth inhibition of human NCI-H522 cells by sulforhodamine B assay Growth inhibition of human NCI-H522 cells by sulforhodamine B assay	[PMID: 19961183]
NCI-H522	GI₅₀	9.14 x 10^-2 μM Compound: 8	Growth inhibition of human NCI-H522 cells by sulforhodamine B assay Growth inhibition of human NCI-H522 cells by sulforhodamine B assay	[PMID: 19961183]
OVCAR-3	GI₅₀	5.19 μM Compound: 8	Growth inhibition of human OVCAR-3 cells by sulforhodamine B assay Growth inhibition of human OVCAR-3 cells by sulforhodamine B assay	[PMID: 19961183]
OVCAR-3	GI₅₀	5.19 x 10^-6 M Compound: 8	Growth inhibition of human OVCAR-3 cells by sulforhodamine B assay Growth inhibition of human OVCAR-3 cells by sulforhodamine B assay	[PMID: 19961183]
OVCAR-4	GI₅₀	3.16 x 10^-5 M Compound: 8	Growth inhibition of human OVCAR4 cells by sulforhodamine B assay Growth inhibition of human OVCAR4 cells by sulforhodamine B assay	[PMID: 19961183]
OVCAR-5	GI₅₀	2.68 x 10^-7 M Compound: 8	Growth inhibition of human OVCAR5 cells by sulforhodamine B assay Growth inhibition of human OVCAR5 cells by sulforhodamine B assay	[PMID: 19961183]
OVCAR-5	GI₅₀	2.68 x 10^-1 μM Compound: 8	Growth inhibition of human OVCAR5 cells by sulforhodamine B assay Growth inhibition of human OVCAR5 cells by sulforhodamine B assay	[PMID: 19961183]
OVCAR-8	GI₅₀	5.74 x 10^-8 M Compound: 8	Growth inhibition of human OVCAR8 cells by sulforhodamine B assay Growth inhibition of human OVCAR8 cells by sulforhodamine B assay	[PMID: 19961183]
OVCAR-8	GI₅₀	5.74 x 10^-2 μM Compound: 8	Growth inhibition of human OVCAR8 cells by sulforhodamine B assay Growth inhibition of human OVCAR8 cells by sulforhodamine B assay	[PMID: 19961183]
PC-3	GI₅₀	4.67 x 10^-7 M Compound: 8	Growth inhibition of human PC3 cells by sulforhodamine B assay Growth inhibition of human PC3 cells by sulforhodamine B assay	[PMID: 19961183]
PC-3	GI₅₀	4.67 x 10^-1 μM Compound: 8	Growth inhibition of human PC3 cells by sulforhodamine B assay Growth inhibition of human PC3 cells by sulforhodamine B assay	[PMID: 19961183]
RXF 393	GI₅₀	1 x 10^-4 M Compound: 8	Growth inhibition of human RXF393 cells by sulforhodamine B assay Growth inhibition of human RXF393 cells by sulforhodamine B assay	[PMID: 19961183]
SF-268	GI₅₀	2.47 x 10^-5 M Compound: 8	Growth inhibition of human SF268 cells by sulforhodamine B assay Growth inhibition of human SF268 cells by sulforhodamine B assay	[PMID: 19961183]
SF-295	GI₅₀	6.55 x 10^-7 M Compound: 8	Growth inhibition of human SF295 cells by sulforhodamine B assay Growth inhibition of human SF295 cells by sulforhodamine B assay	[PMID: 19961183]
SF-295	GI₅₀	6.55 x 10^-1 μM Compound: 8	Growth inhibition of human SF295 cells by sulforhodamine B assay Growth inhibition of human SF295 cells by sulforhodamine B assay	[PMID: 19961183]
SF-539	GI₅₀	6.18 x 10^-8 M Compound: 8	Growth inhibition of human SF539 cells by sulforhodamine B assay Growth inhibition of human SF539 cells by sulforhodamine B assay	[PMID: 19961183]
SF-539	GI₅₀	6.18 x 10^-2 μM Compound: 8	Growth inhibition of human SF539 cells by sulforhodamine B assay Growth inhibition of human SF539 cells by sulforhodamine B assay	[PMID: 19961183]
SH-SY5Y	IC₅₀	3 nM Compound: 8	Cytotoxicity against human SH-SY5Y cells assessed as reduction of total cellular NAD(P) level Cytotoxicity against human SH-SY5Y cells assessed as reduction of total cellular NAD(P) level	[PMID: 19961183]
SH-SY5Y	IC₅₀	3.8 nM Compound: 8	Cytotoxicity against human SH-SY5Y cells assessed as cell viability after 48 hrs by MTT assay Cytotoxicity against human SH-SY5Y cells assessed as cell viability after 48 hrs by MTT assay	[PMID: 19961183]
SH-SY5Y	IC₅₀	3.8 nM Compound: 5	Cytotoxicity against human SH-SY5Y cells Cytotoxicity against human SH-SY5Y cells	[PMID: 21080724]
SK-MEL-2	GI₅₀	1.28 x 10^-5 M Compound: 8	Growth inhibition of human SK-MEL-2 cells by sulforhodamine B assay Growth inhibition of human SK-MEL-2 cells by sulforhodamine B assay	[PMID: 19961183]
SK-MEL-28	GI₅₀	1.59 μM Compound: 8	Growth inhibition of human SK-MEL-28 cells by sulforhodamine B assay Growth inhibition of human SK-MEL-28 cells by sulforhodamine B assay	[PMID: 19961183]
SK-MEL-28	GI₅₀	1.59 x 10^-6 M Compound: 8	Growth inhibition of human SK-MEL-28 cells by sulforhodamine B assay Growth inhibition of human SK-MEL-28 cells by sulforhodamine B assay	[PMID: 19961183]
SK-MEL-5	GI₅₀	2.64 x 10^-5 M Compound: 8	Growth inhibition of human SK-MEL-5 cells by sulforhodamine B assay Growth inhibition of human SK-MEL-5 cells by sulforhodamine B assay	[PMID: 19961183]
SK-OV-3	GI₅₀	2.05 x 10^-5 M Compound: 8	Growth inhibition of human SKOV3 cells by sulforhodamine B assay Growth inhibition of human SKOV3 cells by sulforhodamine B assay	[PMID: 19961183]
SN12C	GI₅₀	4.26 x 10^-8 M Compound: 8	Growth inhibition of human SN12C cells by sulforhodamine B assay Growth inhibition of human SN12C cells by sulforhodamine B assay	[PMID: 19961183]
SN12C	GI₅₀	4.26 x 10^-2 μM Compound: 8	Growth inhibition of human SN12C cells by sulforhodamine B assay Growth inhibition of human SN12C cells by sulforhodamine B assay	[PMID: 19961183]
SNB-19	GI₅₀	4.5 x 10^-7 M Compound: 8	Growth inhibition of human SNB19 cells by sulforhodamine B assay Growth inhibition of human SNB19 cells by sulforhodamine B assay	[PMID: 19961183]
SNB-19	GI₅₀	4.5 x 10^-1 μM Compound: 8	Growth inhibition of human SNB19 cells by sulforhodamine B assay Growth inhibition of human SNB19 cells by sulforhodamine B assay	[PMID: 19961183]
SNB-75	GI₅₀	2.98 x 10^-5 M Compound: 8	Growth inhibition of human SNB75 cells by sulforhodamine B assay Growth inhibition of human SNB75 cells by sulforhodamine B assay	[PMID: 19961183]
SW-620	GI₅₀	6.15 x 10^-8 M Compound: 8	Growth inhibition of human SW620 cells by sulforhodamine B assay Growth inhibition of human SW620 cells by sulforhodamine B assay	[PMID: 19961183]
SW-620	GI₅₀	6.15 x 10^-2 μM Compound: 8	Growth inhibition of human SW620 cells by sulforhodamine B assay Growth inhibition of human SW620 cells by sulforhodamine B assay	[PMID: 19961183]
T47D	GI₅₀	1.23 μM Compound: 8	Growth inhibition of human T47D cells by sulforhodamine B assay Growth inhibition of human T47D cells by sulforhodamine B assay	[PMID: 19961183]
T47D	GI₅₀	1.23 x 10^-6 M Compound: 8	Growth inhibition of human T47D cells by sulforhodamine B assay Growth inhibition of human T47D cells by sulforhodamine B assay	[PMID: 19961183]
TK-10	GI₅₀	1.82 x 10^-5 M Compound: 8	Growth inhibition of human TK10 cells by sulforhodamine B assay Growth inhibition of human TK10 cells by sulforhodamine B assay	[PMID: 19961183]
U-251	GI₅₀	5.21 x 10^-7 M Compound: 8	Growth inhibition of human U251 cells by sulforhodamine B assay Growth inhibition of human U251 cells by sulforhodamine B assay	[PMID: 19961183]
U-251	GI₅₀	5.21 x 10^-1 μM Compound: 8	Growth inhibition of human U251 cells by sulforhodamine B assay Growth inhibition of human U251 cells by sulforhodamine B assay	[PMID: 19961183]
UACC-257	GI₅₀	1.33 x 10^-5 M Compound: 8	Growth inhibition of human UACC257 cells by sulforhodamine B assay Growth inhibition of human UACC257 cells by sulforhodamine B assay	[PMID: 19961183]
UACC-62	GI₅₀	1.33 x 10^-5 M Compound: 8	Growth inhibition of human UACC62 cells by sulforhodamine B assay Growth inhibition of human UACC62 cells by sulforhodamine B assay	[PMID: 19961183]
UO-31	GI₅₀	1.69 x 10^-5 M Compound: 8	Growth inhibition of human UO31 cells by sulforhodamine B assay Growth inhibition of human UO31 cells by sulforhodamine B assay	[PMID: 19961183]

In Vitro

GPP78 (Compound 8; 10 nM; 24-40 hours; SH-SY5Y cells) treatment with cells, punctate staining of LC3-II and the formation of autophagolysosomes are observable. LC3-II is membrane-bound and is present in autophagosomes^[1].
GPP78 (Compound 8) inhibits the growth of most cell lines tested, with nanomolar potency (GI₅₀) in cell lines derived from leukemia, lung, CNS, colon, melanoma, ovarian, renal, and prostate cancers. GPP78 appears truly cytotoxic in melanoma cell lines, while in the others it is mainly cytostatic^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis^[1]

Cell Line:

SH-SY5Y cells
Concentration:

10 nM
Incubation Time:

24 hours, 40 hours
Result:

Punctate staining of LC3-II and the formation of autophagolysosomes were observable.

In Vivo

GPP78 (10 mg/kg; intraperitoneal injection; daily; 1 hour or 6 hours after SCI; for 19 days; male adult CD1 mice) treatment reduces the severity of spinal cord trauma in SCI mice^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Male adult CD1 mice (25-30 g) with spinal cord injury (SCI)^[2]
Dosage:

10 mg/kg
Administration:

Intraperitoneal injection; daily; 1 hour or 6 hours after SCI; for 19 days
Result:

Significantly reduced the demyelination associated with SCI. And significantly ameliorated the functional deficits induced by SCI.

Chemical Information

CAS. Nr. 1202580-59-3
Appearance Liquid
Molecular Weight 439.55
Formel C₂₇H₂₉N₅O
Color Colorless to light yellow
SMILES

O=C(CCCCCCCN1N=NC(C2=CN=CC=C2)=C1)NC3=CC=CC=C3C4=CC=CC=C4
Synonyms

CAY10618
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Solution, -20°C, 2 years

Publications (1)

All

Sort by:

Journal Impact Factor

Sci Signal

Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimetics. [Abstract]

2021 Jun 8;14(686):eabc7405. PMID: 34103421

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (271 KB)
SDS (419 KB)
- English - EN (419 KB)
- Français - FR (419 KB)
- Deutsch - DE (419 KB)
- Norwegian - NO (419 KB)
- Español - ES (419 KB)
- Swedish - SV (419 KB)
- Italian - IT (419 KB)
- Korean - KR (419 KB)
- Portuguese - PT (419 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Colombano G, et al. A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry. J Med Chem. 2010 Jan 28;53(2):616-23. [Content Brief]

[2]. Esposito E, et al. The NAMPT inhibitor FK866 reverts the damage in spinal cord injury. J Neuroinflammation. 2012 Apr 10;9:66. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

GPP78

Publications Citing Use of MedChemExpress (MCE) GPP78